Bellerophon Therapeutics, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q1 2017 to Q3 2023

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Bellerophon Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q1 2017 to Q3 2023.
  • Bellerophon Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2023 was 12.2M shares, a 28.2% increase year-over-year.
  • Bellerophon Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 9.55M shares, a 0.51% increase from 2021.
  • Bellerophon Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 9.5M shares, a 21.9% increase from 2020.
  • Bellerophon Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2020 was 7.8M shares, a 73.1% increase from 2019.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2023 12.2M +2.69M +28.2% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 12.2M +2.69M +28.1% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-14
Q1 2023 10.4M +813K +8.51% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-15
Q4 2022 9.55M +48.1K +0.51% Oct 1, 2022 Dec 31, 2022 10-K 2023-03-31
Q3 2022 9.55M +39K +0.41% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 9.55M +39K +0.41% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 9.55M +54.2K +0.57% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 9.5M +11.7K +0.12% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 9.51M +15.3K +0.16% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 9.51M +1.95M +25.8% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 9.49M +4.88M +106% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-11
Q4 2020 9.49M +4.92M +108% Oct 1, 2020 Dec 31, 2020 10-K 2021-03-11
Q3 2020 9.49M +4.94M +108% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 7.55M +3.01M +66.2% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 4.62M +269K +6.19% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-11
Q4 2019 4.57M +719K +18.7% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-11
Q3 2019 4.55M +706K +18.4% Jul 1, 2019 Sep 30, 2019 10-K 2021-03-11
Q2 2019 4.54M +729K +19.1% Apr 1, 2019 Jun 30, 2019 10-K 2021-03-11
Q1 2019 4.35M +542K +14.3% Jan 1, 2019 Mar 31, 2019 10-K 2021-03-11
Q4 2018 3.85M -51.3M -93% Oct 1, 2018 Dec 31, 2018 10-K 2020-04-06
Q3 2018 3.85M -31.1M -89% Jul 1, 2018 Sep 30, 2018 10-K 2020-04-06
Q2 2018 3.82M -29.7M -88.6% Apr 1, 2018 Jun 30, 2018 10-K 2020-04-06
Q1 2018 3.8M -28.1M -88.1% Jan 1, 2018 Mar 31, 2018 10-K 2020-04-06
Q4 2017 55.1M Oct 1, 2017 Dec 31, 2017 10-K 2019-03-14
Q3 2017 35M Jul 1, 2017 Sep 30, 2017 10-K 2019-03-14
Q2 2017 33.6M Apr 1, 2017 Jun 30, 2017 10-K 2019-03-14
Q1 2017 31.9M Jan 1, 2017 Mar 31, 2017 10-K 2019-03-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.